INSIGHTS ON UPSTREAM MANUFACTURING
-
Improving Scale-Up Starts With Expression Strategy
Early expression screening and strain-engineering strategies can reveal manufacturing risks and clarify which recombinant protein candidates are worth advancing before major investments are made.
-
Why Use The GSquad® Pro Vector System?
Lonza's GSPro® vector platform centers on LHP1, a high-strength promoter developed to improve titer, product quality, and expression stability across a range of recombinant protein formats.
-
How Does GS piggyBac® Transposon Technology Work?
Targeted genomic integration offers a more deliberate path to stable, high-expressing CHO cell lines than random integration methods have traditionally allowed.
-
How Can The GS Effex® Cell Line Increase The Potency Of Therapeutic Antibodies?
Learn how GS Effex® integrates into our GS Gene Expression System®, letting customers use the same expression vectors, GS piggyBac® transposase technology, and media while incorporating the cell line into existing workflows.
-
What Is The GS Discovery® Transient Expression System?9/18/2026
Two transient expression approaches, one optimized for speed and one for higher titers, are examined alongside the consistency advantages of a shared host cell and vector system.
-
How Do I Choose An Expression System For My Biotherapeutic Molecule?9/18/2026
Selecting an expression system early in biotherapeutic development depends on molecular complexity, glycosylation requirements, and other structural characteristics that differ across platforms.
-
Bylok® Platform For IgG-like Bispecific Antibody Assembly9/18/2026
Developing IgG-like bispecific antibodies poses significant expression and product-quality challenges. Discover how the bYlok® platform is designed to address these challenges and enable more efficient bispecific development.
-
Inside The Technology Advancing CHO Therapeutic Protein Expression9/18/2026
Watch as Dr. Peter O'Callaghan, Senior Director and Head of Expression System Sciences, Licensing, answers key questions about the GS Gene Expression System® and the technologies behind its performance.
UPSTREAM MANUFACTURING SOLUTIONS
-
Rushing early development without planning for commercialization can lead to delays. Aligning process and analytical strategies from the start supports efficient scale-up and smoother manufacturing.
-
A stable producer cell line platform designed to replace transient transfection in AAV manufacturing, offering 10 to 15-fold titer improvements and simplified workflows from development through commercial scale.
-
Used 500 liter Cytiva XDR-500 bioreactor system, model XDR-500. Includes (2) Rosemount Analytical model 1056 dual channel intelligent transmitters and (4) peristaltic pump heads, serial# XDR-08825-001, built 2011.
-
Used 500 liter Sartorius Biostat CultiBag single use bioreactor, model STR 500 DW, stainless steel bag holder with agitator drive, jacketed for 1 bar, control system with hmi touch screen, serial# STR-0550, built 2016.
-
Used lot of (2) 10 liter GE Xcellerex (Cytiva) single-use stirred tank bioreactors, model XDR-10. Includes Emerson model 1056 controllers and Mettler Toledo model PBA655-B60 20" x 16" platform scales, serial# 29188443 & 29188442, built 2016.